Allograft Rejection Pathway

After transplantation of organ allografts, there are two pathways of antigen presentation. In the direct pathway, recipient T cells react to intact allogeneic MHC molecules expressed on the surface of donor cells. This pathway would activate host CD4 or CD8 T cells. In contrast, donor MHC molecules (and all other proteins) shed from the graft can be taken up by host APCs and presented to recipient T cells in the context of self-MHC molecules - the indirect pathway. Such presentation activates predominantly CD4 T cells. A direct cytotoxic T-cell attack on graft cells can be made only by T cells that recognize the graft MHC molecules directly. Nontheless, T cells with indirect allospecificity can contribute to graft rejection by activating macrophages, which cause tissue injury and fibrosis, and are also likely to be important in the development of an alloantibody response to graft. (NCI Thesaurus/KEGG)

YOU MAY ALSO LIKE

Allograft

The transplant of an organ, tissue, or cells from one individual to another individual of the same species who is not an…

Allogenicity

A measure of the genetic difference between individuals or organisms. It is a factor in determining if transplants are likely to…

Allogenic Glioma Cancer Vaccine

A vaccine composed of killed glioma cancer cells from another patient for use in immunotherapy.

Allogenic

Taken from different individuals of the same species. Also called allogeneic.

Allogeneic Tumor Cell Vaccine

A vaccine composed of tumor cells isolated from the tumor of one patient, killed and processed, and administered to another patient to…

Allogeneic T-Lymphocytes BPX-501

Allogeneic, T-lymphocytes with potential immune reconstitution activity. Donor T-lymphocytes are transduced with a retroviral vector (BPZ-1001) encoding the inducible suicide gene caspase…